Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Sopheon Terug naar discussie overzicht

Sopheon juni 2018

107 Posts
Pagina: 1 2 3 4 5 6 »» | Laatste | Omlaag ↓
  1. Gartje 1 juni 2018 19:42
    Denk dat we niet echt veel horen pietje, denk wel uitsluitsel over het dividend uitbetalen, en ik hoop dat ze nog een leuke opdracht binnen gesnoept hebben, fijn weekend allemaal
  2. [verwijderd] 2 juni 2018 10:35
    Wel altijd een trading update ! Zou de omzet waar ze zicht hebben al boven de 21.5-22 mij. liggen lijkt me dat, de weg omhoog zeker weer hervat wordt>

    We zullen zien
  3. Gartje 5 juni 2018 18:09
    Koers zit weer in een stijgende lijn richting de trading update, vandaag 4 maal 5000 aandelen over de toonbank, iemand een idee wat we kunnen verwachten overmorgen?
  4. [verwijderd] 5 juni 2018 19:47
    Mijn verwachting is een goede trading update mocht de visible 30% hoger liggen dan vorig jaar 17,5 miljoen *1,3 dus 23 miljoen bijna de totale omzet van 2016 dab kan het weer hard omhoog gaan! Bij meer dan 21-22milj omhoog.
    Ik snap alleen niet van de verkopen en kopen de laatste tijd! lijkt wel een op en neer geschuif. Zou bijna verwachten dat iemand een melding moet gaan maken dat hij of zij minder aandelen hebben of iemand de 3% overschrijdt.
    Maarja wie ben ik. En inderdaad, al dagen 0rders van 5000 voor ongeveer 880.

    En dan deze nog vandaag
    09:25:36 05-Jun-2018 880.50 GBX 19,605 172,622.02 Off-book SINT LRGS

    Lijkt me geen gewone man die dit doet. En Dan gaan ze nog tot 1 miljoen aandelen zelf inkopen(gaat rivermore cashen?)

    Vele vragen nog geen antwoorden hopelijk donderdag meer antwoorden.

    Maar ik verwacht een goede update.

    Wat ik al heb gezegd na de halfjaar cijfers 15 euro.

    Dit is geen beleggingsadvies maar mijn verwachting.
    Met toch wat vragen en met die rare kopen en verkopen ook een beetje onzekerheid.

    Trinko
  5. [verwijderd] 7 juni 2018 08:10
    Your Partner for Innovation Performance™
    Go to...
    Sopheon Logo
    Go to...
    AGM Statement
    AGM Statement
    At today’s Annual General Meeting of Sopheon, the international provider of software and services that help organizations generate more revenues and profits from new products, the Board will give shareholders an update and review of the business.

    In conjunction with a truly exceptional financial performance in 2017, we continue to advance our strategy to be the world’s leading provider of enterprise-class innovation management solutions. Our vision has consistently led the market, and this is a market that continues to evolve and demonstrate considerable growth. We delivered a very strong finish to last year, resulting in all the Group’s headline financial measures exceeding market expectations by a significant margin. Revenues rose to $28.5m from $23.2m in 2016. On the back of an already strong increase in profitability in 2016, EBITDA last year reached $8.0m, up from $5.6m the year before, and profit before tax was $5.1m, compared to $3.0m the year before. Alongside a realignment of our debt position, this resulted in net assets rising to $18.6m from $10.4m the year before, and net cash rising to $9.5m from $4.2m.

    Both volume and average value of license transactions increased compared to the year before. Towards the end of 2017 we signed substantial deals with two industry leading, blue chip companies in the USA and in Germany and we are now in the process of implementing our Accolade® solution globally in both cases. Such customers further validate the momentum and acceptance of Accolade as an enterprise platform within the largest and most influential corporations in the world. We saw more acceptance of our SaaS (Software as a Service) offering, with three new SaaS customers signed last year, and our recurring revenue base improved to over $12m by the end of the year compared to just under $10m the year before.

    Sopheon’s market differentiation continues to be validated. Sopheon is the only vendor recognized in three different Gartner Market Guides — for Strategy Execution Management Software; Innovation Management Tools; and Strategy & Innovation Roadmapping Tools – as well as in its Magic Quadrant for Project Portfolio Management Worldwide. In our view, the capabilities called for in all of these respective reports are required to deliver on the promise of connecting strategic planning and operational execution. In addition, Sopheon was named a Leader in the 2017 Forrester Wave™: Strategic Portfolio Management Tools. Further recent market validation was recognition by Consumer Goods Technology magazine, naming Sopheon as “Best in Category” in new product development and introduction as voted by readers. Collectively, these are major strategic milestones in establishing the credentials of both the Company and our market.

    In order to deliver on our growth strategies as described in our annual report, we are executing on ambitious investment plans across multiple functional areas to scale for growth for 2018 and beyond. Where appropriate, we are also open to consideration of targeted M&A opportunities if consistent with our goals and focused investment criteria. Alongside strategic initiatives, we remain highly driven by revenue and profit objectives, and to stand behind this ambition we have proposed a maiden dividend, to be put to the Company’s shareholders at today’s meeting. Remaining on the corporate theme, we were delighted with the success of our oversubscribed secondary placing completed in mid-May, which expanded our institutional shareholder base, and we are grateful for the support and demand shown by certain blue chip institutional investors for the Company’s shares.

    Outlook

    The positive momentum has continued this year, and we are signing additional new business, which in turn is underpinning the performance for the year. Full year revenue visibility for 2018 from contracted business and recurring revenue streams is now up 34% at $23.5m, compared to $17.5m at this time last year – an all-time high for our mid-year AGM report. This includes the effect of several perpetual license deals and major services extensions, as well as a further major SaaS deal closed during the current quarter.

    The Board continues to be confident and enthusiastic about the prospects of the Company, the outturn for the year and the opportunity to continue to deliver on our vision.

    For Further Information Contact:

    Barry Mence, Chairman
    Arif Karimjee, CFO Sopheon plc + 44 (0) 1276 919 560
    Carl Holmes / Giles Rolls (corporate finance)
    Alice Lane (corporate broking) finnCap + 44 (0) 20 7220 0500

    The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.
    About Sopheon
    Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon’s Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon’s solutions have been implemented by over 250 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange.

    Print Friendly, PDF & EmailPrint
    June 7th, 2018
    Share This Story, Choose Your Platform!
    FacebookTwitterLinkedinGoogle+Email
    INVESTORS
    Board of Directors
    Corporate Information
    Financial Releases
    Financial Reports
    Investors FAQs
    Analysts & Research
    Request Investor Info
    NEWSLETTER
    Register Here
    WEBINARS & VIDEOS
    Upcoming Webinar: Innovation Overdrive: Align the Moving Parts with Speed and Agility
    Expanding Sopheon’s Footprint and Seizing Growth Opportunities
    #DigInnovation: Enabling companies to transform with speed and agility
    RECENT POSTS
    AGM Statement
    Upcoming Webinar: Innovation Overdrive: Align the Moving Parts with Speed and Agility
    How to Assign the Right Metrics to Drive Portfolio Performance
    RECENT TWEETS
    #TeamSopheon has junior to senior level software engineer positions open ow.ly/RrgT30knjBb pic.twitter.com/IYOxgzUNPq

    6 hours ago
    ? “ World Environment Day 2018” by @covestro twitter.com/i/moments/1003… #TeamAccolade

    1 day ago
    RSS Feeds | Sitemap | Privacy | Legal | Contact Us :: Copyright 2018 Sopheon. All Rights Reserved
    RssTwitterYouTubeGoogle+LinkedinFacebook
    This site uses cookies to store information on your computer.
    Some of these cookies are essential to make our site work and others help us to improve by giving us some insight into how the site is being used.

    Information will be used in accordance with our Privacy Policy

    Accept Recommended Settings
    Necessary Cookies
    Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.

    Analytic Cookies
    Enable
    Disable
    Analytic cookies help us to improve our website by collecting and reporting usage information.

    Advertising Cookies
    Enable
    Disable
    Advertising cookies track visitors across websites so targeted ad content can be displayed based on individual users interests.

    Preference Cookies
    Enable
    Disable
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.

  6. [verwijderd] 7 juni 2018 08:20
    Weinig echt nieuws te melden zo te lezen, behalve:

    recurring revenue base improved to over $12m by the end of the year compared to just under $10m the year before.

    Full year revenue visibility for 2018 from contracted business and recurring revenue streams is now up 34% at $23.5m, compared to $17.5m at this time last year – an all-time high for our mid-year AGM report.

    ...en dat laatste is natuurlijk wel weer heel goed nieuws.
  7. Gartje 7 juni 2018 08:33
    Weet niet hoe de markt er op gaat reageren maar in deze onzekere tijd met die pipo in Amerika vind ik dit een prima update, de groei gaat maar door en door!!
  8. Gartje 7 juni 2018 08:38
    we are grateful for the support and demand shown by certain blue chip institutional investors for the Company’s shares. Vond ik ook wel aardig!!
107 Posts
Pagina: 1 2 3 4 5 6 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.846
AB InBev 2 5.308
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.580 47.023
ABO-Group 1 19
Acacia Pharma 9 24.692
Accell Group 151 4.129
Accentis 2 253
Accsys Technologies 22 9.030
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 160
ADMA Biologics 1 32
Adomos 1 126
AdUX 2 457
Adyen 13 16.606
Aedifica 2 832
Aegon 3.257 320.321
AFC Ajax 537 7.025
Affimed NV 2 5.778
ageas 5.843 109.784
Agfa-Gevaert 13 1.895
Ahold 3.536 74.015
Air France - KLM 1.024 34.390
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.778
Alfen 13 17.032
Allfunds Group 3 1.236
Almunda Professionals (vh Novisource) 651 4.247
Alpha Pro Tech 1 17
Alphabet Inc. 1 341
Altice 106 51.196
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.771
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.821 240.469
AMG 965 126.492
AMS 3 73
Amsterdam Commodities 303 6.527
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 383
Antonov 22.632 153.605
Aperam 91 14.188
Apollo Alternative Assets 1 17
Apple 5 322
Arcadis 251 8.628
Arcelor Mittal 2.024 318.761
Archos 1 1
Arcona Property Fund 1 269
arGEN-X 15 9.177
Aroundtown SA 1 184
Arrowhead Research 5 9.311
Ascencio 1 20
ASIT biotech 2 697
ASMI 4.107 37.764
ASML 1.762 77.556
ASR Nederland 18 4.162
ATAI Life Sciences 1 7
Atenor Group 1 335
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 29 10.776
Axsome Therapeutics 1 177
Azelis Group 1 49
Azerion 7 2.681

Beleggingsideeën van onze partners

Macro & Bedrijfsagenda

  1. 21 mei

    1. Envipco Q1-cijfers
    2. Fagron ex €0,30 dividend
    3. Euronext ex €2,48 dividend
    4. Shell jaarvergadering in Londen
    5. Handelsbalans maart (eurozone)
    6. Lowe's Q1-cijfers
    7. Macy's Q1-cijfers
    8. Pharming jaarvergadering
  2. 22 mei

    1. Aalberts Q1-cijfers
    2. Prijzen bestaande koopwoningen april (NL)
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht